MELODY BARKER: Open Payments
NPI 1942591250 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,421 in 103 payments from 18 companies in 2025. Trend: 2023 $622 · 2024 $942 · 2025 $1,421
Food & beverage: $1,421
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 54 | $535 |
| Corcept Therapeutics | 10 | $175 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $172 |
| GlaxoSmithKline, LLC. | 9 | $138 |
| PFIZER INC. | 3 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $57 |
| Antares Pharma, Inc. | 2 | $33 |
| Eisai Inc. | 1 | $31 |
| Lilly USA, LLC | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $25 |
Products named: VRAYLAR, Korlym, Kerendia, UBRELVY, QULIPTA, TRELEGY ELLIPTA, NURTEC ODT, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
